Uzbekistan and Algeria held discussions on prospects for cooperation in the pharmaceutical industry, including the possibility of local insulin production in Uzbekistan.
Tashkent, Uzbekistan (UzDaily.uz)
The negotiations took place on November 5, 2026, between Abdullah Azizov, Director of the Agency for the Development of Medical and Pharmaceutical Industry, and Amir Habes, CEO of the Algerian company BioCare Group. The parties discussed the potential for expanding pharmaceutical production in Uzbekistan, efficient use of existing production capacities, attracting foreign investment, and implementing new technologies.
Particular attention was paid to a possible partnership in the field of insulin production. The participants considered the application of advanced technologies and international experience to establish local production. Furthermore, the sides exchanged views on defining mutually beneficial areas of cooperation and implementing joint projects.
However, the announcement did not specify any concrete agreements regarding the launch of production or project timelines.


